Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chase, W"'
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37
Background: AVFs are the lifeline of dialysis patients, but can often occlude. The most common cause of AVF failure is inflammation-driven neointimal hyperplasia and thrombosis. Here, we investigated whether statin therapy with well-recognized anti-i
Autor:
Ralph Weissleder, Jason R. McCarthy, Chunqiang Li, Crystal M. Ripplinger, Farouc A. Jaffer, Charles P. Lin, Peter K. Henke, Chase W. Kessinger, Jin Won Kim
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 32:2616-2624
Objective— Assessment of thrombus inflammation in vivo could provide new insights into deep vein thrombosis (DVT) resolution. Here, we develop and evaluate 2 integrated fluorescence molecular-structural imaging strategies to quantify DVT-related in
Autor:
Tetsuya Hara, Ralph Weissleder, Brijesh Bhayana, Guillermo J. Tearney, Jason R. McCarthy, Ashok Khatri, Chase W. Kessinger, Brian Thompson, Farouc A. Jaffer, Charles P. Lin
Publikováno v:
JACC: Cardiovascular Imaging. 5(6):607-615
ObjectivesThe goal of this study was to develop and validate a new fibrin-targeted imaging agent that enables high-resolution near-infrared fluorescence (NIRF) imaging of deep vein thrombosis (DVT).BackgroundNIRF imaging of fibrin could enable highly
Autor:
Ahmed Tawakol, Farouc A. Jaffer, Kimmo Jokivarsi, Peter K. Henke, Tetsuya Hara, Anna-Liisa Brownell, William J. Hucker, Megan H. MacNabb, Jessica Truelove, Ralph Weissleder, Chase W. Kessinger, Gregory R. Wojtkiewicz, Michael R. Jaff
Publikováno v:
Circulation. 131(24)
We thank Dr Klok and colleagues for their comments on our article.1 Deep venous thrombosis (DVT) is a relatively common disorder that is associated with potentially deadly complications, such as pulmonary embolism, and carries a substantial risk for
Autor:
Jason R. McCarthy, Jin Won Kim, Peter Libby, Martin Sillesen, Ralph Weissleder, Chase W. Kessinger, Brian Thompson, Tetsuya Hara, Ronan Margey, Farouc A. Jaffer, Charles P. Lin, Peter K. Henke
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116621 (2015)
PLoS ONE
PLoS ONE
Despite anticoagulation therapy, up to one-half of patients with deep vein thrombosis (DVT) will develop the post-thrombotic syndrome (PTS). Improving the long-term outcome of DVT patients at risk for PTS will therefore require new approaches. Here w
Autor:
Peter Libby, Jason R. McCarthy, David E. Sosnovik, Chase W. Kessinger, Jie Cui, Ravi Thadhani, Farouc A. Jaffer
Objective— In vivo assessment of pathological endothelium within arteriovenous fistula (AVF) could provide new insights into inflow stenosis, a common cause of AVF primary failure in end-stage renal disease patients. Here we developed nanoparticle-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16b51ae1deaffc7f64330ef2ed5a2d2
https://europepmc.org/articles/PMC4270948/
https://europepmc.org/articles/PMC4270948/
Autor:
Michael R. Jaff, Jessica Truelove, Megan H. MacNabb, Tetsuya Hara, Ahmed Tawakol, Farouc A. Jaffer, Peter K. Henke, Chase W. Kessinger, Gregory R. Wojtkiewicz, Ralph Weissleder, Kimmo Jokivarsi, Anna-Liisa Brownell, William J. Hucker
Background— Accurate detection of recurrent same-site deep vein thrombosis (DVT) is a challenging clinical problem. Because DVT formation and resolution are associated with a preponderance of inflammatory cells, we investigated whether noninvasive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f28926bfabaf30f166f2fa1d51cdd90a
https://europepmc.org/articles/PMC4174982/
https://europepmc.org/articles/PMC4174982/
Autor:
Peter K. Henke, Willam J Hucker, Ralph Weissleder, Ahmed Tawakol, Megan H. MacNabb, Jessica Truelove, Chase W. Kessinger, Gregory R. Wojtkiewicz, Farouc A. Jaffer, Tetsuya Hara
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 34
Background: Specific detection of recurrent deep vein thrombosis (DVT) is a challenging clinical problem. As DVT formation and resolution are inflammatory processes, we experimentally investigated whether noninvasive 18F-fluorodeoxyglucose (FDG)-PET
Autor:
Chase W Kessinger, Jin Won Kim, Brian Thompson, Martin Sillesen, Tetsuya Hara, Jason R McCarthy, Charles P Lin, Peter K Henke, Farouc A Jaffer
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 33
Introduction In deep vein thrombosis (DVT), both the induced inflammation response and fibrinolytic capacity are critical in resolving experimental DVT. Unresolved, obstructing thrombi can lead to the burdensome and costly sequelae of the post-thromb
Autor:
Ashley F Stein, Chase W Kessinger, Henry Zalada Castro, S S Erdem, Jason R McCarthy, Charles P Lin, Farouc A Jaffer
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 33
Introduction Tissue plasminogen activator (tPA) is increasingly used to treat deep vein thrombosis (DVT) to prevent the post-thrombotic syndrome. However, while aging venous thrombi are likely to become resistant to fibrinolysis, the age-dependent re